FDA permits marketing of device to help reduce opioid withdrawal symptoms
On Nov. 15, the U.S. Food and Drug Administration (FDA) granted a new indication to an electric stimulation device (NSS-2 Bridge) for use in…




*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.